Literature DB >> 10799498

Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins.

L Gong1, T Kamitani, S Millas, E T Yeh.   

Abstract

Covalent conjugation of proteins by ubiquitin or ubiquitin-like molecules is an important form of post-translational modification and plays a critical role in many cellular processes. Similar to the concept of phosphorylation and dephosphorylation, these conjugates are regulated by a large number of deconjugating enzymes. Here, we report the cloning of a 2,141-base pair DNA fragment from human placenta cDNA library by a strategy that involves expressed sequence tag data base searching, polymerase chain reaction, and rapid amplification of cDNA ends. Nucleotide sequence analysis revealed that the cloned cDNA contains an open reading frame of 1,143 base pairs encoding a novel protease, USP21, which is composed of 381 residues with a calculated molecular mass of 43 kDa. The human USP21 gene is located on chromosome 1q21 and encodes a member of the ubiquitin-specific protease family with highly conserved Cys and His domains. The activity and specificity of USP21 were determined by using a COS cell expression system in vivo. We showed that USP21 is capable of removing ubiquitin from ubiquitinated proteins as expected. Furthermore, USP21 is capable of removing NEDD8 from NEDD8 conjugates but has no effect on Sentrin-1 conjugates. As expected from its biochemical activity, overexpression of USP21 has a profound growth inhibitory effect on U2OS cells. Thus, USP21 is the first ubiquitin-specific protease shown to have dual specificity for both ubiquitin and NEDD8 and may play an important role in the regulation of cell growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799498     DOI: 10.1074/jbc.275.19.14212

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  The role of deubiquitinating enzymes in apoptosis.

Authors:  Suresh Ramakrishna; Bharathi Suresh; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

Review 2.  Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy.

Authors:  Tomoaki Tanaka; Tatsuya Nakatani; Tetsu Kamitani
Journal:  Mol Oncol       Date:  2012-01-21       Impact factor: 6.603

3.  sNASP inhibits TLR signaling to regulate immune response in sepsis.

Authors:  Feng-Ming Yang; Yong Zuo; Wei Zhou; Chuan Xia; Bumsuk Hahm; Mark Sullivan; Jinke Cheng; Hui-Ming Chang; Edward Th Yeh
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

Review 4.  Breaking the chains: structure and function of the deubiquitinases.

Authors:  David Komander; Michael J Clague; Sylvie Urbé
Journal:  Nat Rev Mol Cell Biol       Date:  2009-08       Impact factor: 94.444

Review 5.  Function and regulation of protein neddylation. 'Protein modifications: beyond the usual suspects' review series.

Authors:  Gwénaël Rabut; Matthias Peter
Journal:  EMBO Rep       Date:  2008-09-19       Impact factor: 8.807

6.  USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria.

Authors:  Christian N Cunningham; Joshua M Baughman; Lilian Phu; Joy S Tea; Christine Yu; Mary Coons; Donald S Kirkpatrick; Baris Bingol; Jacob E Corn
Journal:  Nat Cell Biol       Date:  2015-01-26       Impact factor: 28.824

7.  NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8 to proteasome for degradation through the P97UFD1/NPL4 complex.

Authors:  Shuai Liu; Hui Yang; Jian Zhao; Yu-Hang Zhang; Ai-Xin Song; Hong-Yu Hu
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

Review 8.  Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.

Authors:  Yongchao Zhao; Meredith A Morgan; Yi Sun
Journal:  Antioxid Redox Signal       Date:  2014-02-20       Impact factor: 8.401

Review 9.  DUBbing Down Translation: The Functional Interaction of Deubiquitinases with the Translational Machinery.

Authors:  Bandish B Kapadia; Ronald B Gartenhaus
Journal:  Mol Cancer Ther       Date:  2019-09       Impact factor: 6.261

10.  Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins.

Authors:  Joris Hemelaar; Anna Borodovsky; Benedikt M Kessler; David Reverter; Julie Cook; Nagamallesawari Kolli; Tudev Gan-Erdene; Keith D Wilkinson; Grace Gill; Christopher D Lima; Hidde L Ploegh; Huib Ovaa
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.